RNU6-531P

Across TCGA pan-cancer cohorts, RNU6-531P RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated RNU6-531P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-531P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU6-531P expression acts as an unfavorable survival marker, although some lineages such as KIRC and HNSC show a favorable association.

KIRC, HNSC, and LUAD are the cancer types where RNU6-531P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.732	0.542	<.001	108	view →
HNSC	DFS	Quartile	III,IV	0.773	0.566	.002	56	view →
LUAD	OS	Tertile	III,IV	0.615	0.381	.012	32	view →
UVM	DFS	Quartile	III,IV	0.262	0.922	.004	29	view →
MESO	DFS	Median	III,IV	0.210	0.626	.004	27	view →
LIHC	DFS	Quartile	All	0.329	0.494	.002	23	view →
BRCA	DFS	Quartile	III,IV	0.942	0.783	.008	20	view →
CESC	DFS	Quartile	All	0.417	0.781	.001	18	view →
LAML	DFS	Quartile	All	0.519	0.325	.025	14	view →
DLBC	OS	Tertile	All	0.777	0.975	.034	13	view →
SKCM	DFS	Quartile	All	0.256	0.149	.003	12	view →
UCEC	OS	Tertile	All	0.897	0.940	.029	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

RNU6-531P–KIRC (OS)

Open the KIRC breakdown →